Scientists hunt for clues to make cancer cell therapy more predictable
NCT ID NCT07236203
Summary
This study aims to discover what factors predict whether a powerful cell therapy (CAR-T) will work for patients with large B-cell lymphoma that has returned or not responded to other treatments. Researchers will follow 80 patients receiving standard CAR-T therapy to analyze their health data, tumor details, and immune system changes. The goal is to learn which patients are most likely to benefit, helping guide future treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 200231, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.